Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Identify lessons from common budgeting mistakes to enhance forecasting accuracy and build a stronger, more adaptable financial plan.
27,725 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Bitcoin has moved sharply after its peak, creating a dilemma for investors. This guide breaks down what bitcoin after...
Security researchers warn that the next DeFi exploit will likely begin in the developer supply chain, exploiting pack...
A pivotal AI funding milestone shifts how investors view tech giants. Learn what the Anthropic move signals for Amazo...
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...
As SM Energy reports Q4 2025 results, investors gain a window into the company's production mix, costs, and capital p...
Medtronic stock popped today after the company topped earnings expectations and revenue forecasts. This article expla...
As July earnings approach, investors ask if taiwan semiconductor stock before July is a smart move. This guide breaks...
After years of eye-popping gains, investors wonder if Nvidia and Broadcom still have room to run. This guide uses his...
Micron stock losing ground sparks questions about memory cycles, AI-driven demand, and macro risks. This article brea...
A veteran tech executive exits a long career with a concentrated stock stake worth $1.6 million, setting up a high-st...
As inflation changes, social security recipients could see a bigger 2027 COLA. This article breaks down what that mea...